Laboratorios Farma | ROVI - Nettoeinkommen

Aktienkurs
78.63
Täglich Wechseln
-1.88 -2.33%
Monatlich
0.10%
Jährlich
49.76%
Q1 Prognose
76.74




Nettoeinkommen Veränderung Datum
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Alaunos Therapeutics USD -1.16M 108K 2025-09
Almirall EUR 19.58M 7M 2025-12
Avita Medical AUD -11.62M 1.7M 2025-12
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -229M 100.39M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Laboratorios Farma EUR 103.69M 37.04M 2023-12
Moderna USD -200M 625M 2025-09
Organon & Co USD 160M 15M 2025-09
Pharma Mar EUR 59.66M 63.76M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Tectonic Therapeutic USD -19.23M 186K 2025-12
Viatris USD -340.1M 211.9M 2025-12
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12